If people can't read up on the clues,I sure advise you to stay away from investing in the stock markets in general. Here are some of the pointers which indicate to a buyout:-
1) New gUY ON THE bOARD!!!
2) New Guy is famous for sellout's at large premiums to big Pharma!
3)Institutions are increasing their stake in the company
4)King and his compadres have done this before and will do it again.
5) Dr Zaffaroni is 92 yrs old and he has done this for over 50 yrs now,he won't stop at ALXA.
6)Partners a.k.a distribution networks are already in place in EU,US to follow
7) Last but not the least,this technology is unique and patented. See FDA website on the pledge many big pharma and FDA have made going forward--greater emphasis and marketing of medical delivery devices and unique delivery methods.
I would be really interested to see the next 3 motnhs of this stock. LONG and STRONG!
Sentiment: Strong Buy
King announced that Adasuve would be ready for release to the market In the US & the EU in the 3rd qtr. of 2013. Wouldn't be supprised to see an announce buy=out prior to release of product-The technology IMHO, is very valuable.
I'd have to agree, this Buchi guy most likely was brought on board to see if he could sale the company. Product does seem like an effective delivery system with other drug applications. The only concern I have is that they couldn't sell the company themselves. They had to bring this guy in. Hope he's a good car salesman. I'd agree with you, looks like it could take up to 3 months or so to find a buyer and work out a price. So there's still time to buy at these levels.
we have to wait for next 3 months,I don't think so....They might be in advanced stage of negotiations!
In a week or a month we may see a deal here.
Thats why they brought this guy immediately and created new entry in BOD and paid him 20,000 shares option, getting $1m for 1-4 weeks worth of work? who willn't say no!!
Anothere reason I think the BO is on the horizon, they didn't picked up any parther like they did in 2010 with Bolivial b4 FDA PDUFA and we didn't see any PR about MIXED SEC offering like most Pharmas do b4 or after FDA Approvals. We are already two weeks since we got approval and we hear two +ve developments so far...and don't forget about a PR in late December 2011 when they laid off and retained Lazard for strategic options.